Company Data
Outlook Therapeutics Inc.
Ticker
OTLK
Current Price
$1.53 6.25%
Market Cap
$49.0M
Price Target
Refer to Report
Volume
200.9K
52wk Range
$0.87 - $9.25
Overview
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.